<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>UNLABELLED: BACKGROUND /AIMS: The aim of this study was to calculate the prevalence of elevated carcinoembryonic antigen (CEA) among <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) patients and to evaluate the prognostic value of preoperative serum CEA levels in them </plain></SENT>
<SENT sid="1" pm="."><plain>METHODOLOGY: Between 1995 and 2005, 8,861 consecutive patients were enrolled from a prospective database </plain></SENT>
<SENT sid="2" pm="."><plain>CEA =5ng/mL was defined as elevated CEA </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: In the multivariate analysis, elevated preoperative CEA correlated with higher ages, circumferential <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumors</z:e>, large <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> and high-stage (AJCC) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>After a 44-month median follow-up, elevated CEA was found to be an independent prognostic factor (odds ratio = 1.61) for overall survival in <z:hpo ids='HP_0000001'>all</z:hpo> 4 stages of the disease </plain></SENT>
<SENT sid="5" pm="."><plain>The survival among patients with stage I <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and elevated CEA (5-year survival rate = 74.7%) was not greater than that among patients with stage II <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and no CEA elevation (5-year survival rate = 80.8%) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Elevated preoperative CEA correlated with a higher age, circumferential <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumors</z:e>, large <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e>, and high-stage (AJCC) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Elevated preoperative CEA indicates a potential poor prognosis even in early stage <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>This poorer prognosis in the patients with stage I <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and elevated preoperative CEA was not <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> specific </plain></SENT>
</text></document>